Sterling Heights Cosmetic Surgeon Becomes First in Area to Offer New FDA-cleared Cellulite Treatment

Sterling Heights, MI - July 2005 - Dr. Mark Berkowitz today announced the availability of the VelaSmooth for the treatment of cellulite at its office. The VelaSmooth, the first and only medical device cleared to treat cellulite by the U.S. Food and Drug Administration (FDA), offers patients a non-surgical, no downtime treatment for the appearance of cellulite.

Cellulite is a term used to describe the pitting, bulging and ripple effect of the skin usually affecting the thighs, buttocks, hips, breasts and the abdomen of women. More than 80 percent of women above the age of 18 have cellulite, regardless of their size, weight or physical fitness. Women are more likely to have cellulite than men as men’s fat cells reside deeper within the skin, while women’s are closer to the surface causing the ripples associated with cellulite.

Studies on the VelaSmooth found that patients had an average reduction of 4.00 cm to the circumference of their thigh, an average 5.50 cm reduction in their abdominal area and 5.70 cm for their hips. The VelaSmooth offers a quick and no downtime method to reduce the appearance of the “cottage cheese” bump effect on their skin - and men love what the VelaSmooth does for their “love handles.” Treatment approach calls for an eight week, twice weekly appointment schedule.

“We are committed to providing our patients with the best aesthetic technology available,” said Dr. Mark Berkowitz, Medical Director, Accents Cosmetic Surgery and Medical Spa. “With VelaSmooth’s successful combination of RF and Infrared Light along with the added benefit of negative pressure tissue mobilization, there is now a solution available to effectively treat cellulite and re-contour common problem areas.”

The synergy of the three components used to create the VelaSmooth’s technology makes it an effective treatment for those seeking a medical cellulite solution. Because the VelaSmooth is an FDA-cleared medical device, it is only sold to physicians for use by trained professionals under their medical direction.

Syneron Medical Ltd. (Nasdaq: ELOS - News) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos(TM) combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Founded in 2000, Syneron Medical Ltd. has offices and distributors throughout the world including North American Headquarters in Canada and European Headquarters in Germany, which provide sales, service and support. Additional information can be found at http://www.syneron.com.

About Accents Cosmetic Surgery and Medical Spa
For over 10 years, Dr. Berkowitz has transformed his patients' visions of beauty into reality by sculpting sagging skin, re-defining drooping jowls, renewing facial contours and improving the appearance of aging, sun-damaged and flawed skin. He is one of a small group of surgeons in Michigan to be recognized for his specialized skills by both the American Academy of Cosmetic Surgery and the American Society of Ocular Plastic and Reconstructive Surgery. Dr. Berkowitz is a Board Certified and Fellowship trained Ocular Plastic and Reconstructive Surgeon.

In June 2006, Dr. Berkowitz opened an extraordinary medical spa where men and women of all ages are able to experience both surgical and non-surgical cosmetic enhancement and anti-aging treatments. For more information Dr. Berkowitz is available for interview by appointment; photographers are welcome.

News Source: Accents Cosmetic Surgery and Medical Spa